Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Clearmind Medicine Inc.

    NASDAQ: CMND · Real-Time Price · USD
    0.83
    -0.03 (-3.07%)
    At close: Jun 13, 2025, 3:56 PM
    0.84
    0.60%
    After-hours: Jun 13, 2025, 07:48 PM EDT

    Clearmind Medicine Statistics

    Share Statistics

    Clearmind Medicine has 5.13M shares outstanding. The number of shares has increased by 62% in one year.

    Shares Outstanding

    n/a
    		 5.13M

    Shares Change (YoY)

    n/a
    		 62%

    Shares Change (QoQ)

    n/a
    		 17.15%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 4.81M

    Failed to Deliver (FTD) Shares

    n/a
    		 611

    FTD / Avg. Volume

    n/a
    		 0.25%

    Short Selling Information

    The latest short interest is 105.68K, so 2.06% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 105.68K

    Short % of Shares Out

    n/a
    		 2.06%

    Short % of Float

    n/a
    		 2.13%

    Short Ratio (days to cover)

    n/a
    		 1.63

    Valuation Ratios

    The PE ratio is -1.13 and the forward PE ratio is null. Clearmind Medicine's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -1.13

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.91

    P/FCF Ratio

    n/a
    		 -1.22

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Clearmind Medicine.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 1.72

    Quick Ratio

    n/a
    		 1.72

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 -174.23

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,313,669.5

    Employee Count

    n/a
    		 4

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 377.97K

    Effective Tax Rate

    n/a
    		 -7.75%

    Stock Price Statistics

    The stock price has increased by -25.23% in the last 52 weeks. The beta is -1.31, so Clearmind Medicine's price volatility has been lower than the market average.

    Beta

    n/a
    		 -1.31

    52-Week Price Change

    n/a
    		 -25.23%

    50-Day Moving Average

    n/a
    		 0.97

    200-Day Moving Average

    n/a
    		 1.24

    Relative Strength Index (RSI)

    n/a
    		 32.05

    Average Volume (20 Days)

    n/a
    		 245,331

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -26.7K

    Operating Income

    n/a
    		 -6.3M

    Net Income

    n/a
    		 -5.25M

    EBITDA

    n/a
    		 -5.85M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.7
    Full Income Statement

    Balance Sheet

    The company has 6.57M in cash and 53.14K in debt, giving a net cash position of 6.52M.

    Cash & Cash Equivalents

    n/a
    		 6.57M

    Total Debt

    n/a
    		 53.14K

    Net Cash

    n/a
    		 6.52M

    Retained Earnings

    n/a
    		 -24.02M

    Total Assets

    n/a
    		 6.58M

    Working Capital

    n/a
    		 2.69M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.86M and capital expenditures 0, giving a free cash flow of -4.86M.

    Operating Cash Flow

    n/a
    		 -4.86M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -4.86M

    FCF Per Share

    n/a
    		 -1.14
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CMND does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CMND.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 28, 2023. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Nov 28, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -6.75

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist